Cargando…

Qici Sanling Decoction Suppresses Glutamine Consumption and Bladder Cancer Cell Growth through Inhibiting c-Myc Expression

Traditional Chinese medicine (TCM) is widely used as an alternative therapy for cancer treatment in China. Glutamine catabolism plays an important role in cancer development. Qici Sanling decoction (QCSL) suppresses bladder cancer growth. However, the association between QCSL and glutamine catabolis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Weihua, Wang, Weifeng, Zhang, Jun, Liao, Guoqiang, Bai, Jie, Yang, Bo, Tan, Mingyue, Gong, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766179/ https://www.ncbi.nlm.nih.gov/pubmed/35058981 http://dx.doi.org/10.1155/2022/7985468

Ejemplares similares

Qici Sanling decoction suppresses bladder cancer growth by inhibiting the Wnt/Β-catenin pathway
por: Gong, Hua, et al.
Publicado: (2019)

c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism
por: Gao, Ping, et al.
Publicado: (2009)

Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells
por: Yuneva, Mariia, et al.
Publicado: (2007)

Glutamine metabolism and the unfolded protein response in MYC-driven breast cancer
por: Shajahan-Haq, Ayesha, et al.
Publicado: (2014)

MYC-induced reprogramming of glutamine catabolism supports optimal virus replication
por: Thai, Minh, et al.
Publicado: (2015)

Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma()()
por: Hanaford, Allison R., et al.
Publicado: (2019)

Rhophilin-2 Upregulates Glutamine Synthetase by Stabilizing c-Myc Protein and Confers Resistance to Glutamine Deprivation in Lung Cancer
por: Xiao, Dakai, et al.
Publicado: (2021)

Loss of Heterozygosity for Kras(G12D) Promotes Malignant Phenotype of Pancreatic Ductal Adenocarcinoma by Activating HIF-2α-c-Myc-Regulated Glutamine Metabolism
por: Ma, Yu, et al.
Publicado: (2022)

Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation
por: Le Grand, Marion, et al.
Publicado: (2020)

Antagonistic effects of MYC and hypoxia in channeling glucose and glutamine into de novo nucleotide biosynthesis
por: Fan, Teresa, et al.
Publicado: (2014)

Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction
por: Fogal, Valentina, et al.
Publicado: (2014)

Glucose- and glutamine-fueled stabilization of C-Myc is required for T-cell proliferation and malignant transformation
por: Gabriel, SS, et al.
Publicado: (2016)

MYC regulation of glutamine–proline regulatory axis is key in luminal B breast cancer
por: Craze, Madeleine L, et al.
Publicado: (2018)

MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype
por: Tambay, Vincent, et al.
Publicado: (2021)

MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer
por: Shajahan-Haq, Ayesha N, et al.
Publicado: (2014)

Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth
por: Ye, Jianxin, et al.
Publicado: (2018)

LincRNA-p21 suppresses glutamine catabolism and bladder cancer cell growth through inhibiting glutaminase expression
por: Zhou, Qun, et al.
Publicado: (2019)

Qualitative and Quantitative Analysis of 24 Components in Jinlianhua Decoction by UPLC–MS/MS
por: Fang, Mingyue, et al.
Publicado: (2019)

Urge suppression and modified fluid consumption in the management of female overactive bladder symptoms
por: Pal, Manidip, et al.
Publicado: (2021)

SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis
por: Xu, Kangdi, et al.
Publicado: (2022)

Exercise-Mediated Lowering of Glutamine Availability Suppresses Tumor Growth and Attenuates Muscle Wasting
por: Pedersen, Katrine S., et al.
Publicado: (2020)

Effects of Buzhong Yiqi Decoction Combined with THP Bladder Perfusion on Postoperative Efficacy in Patients with Bladder Cancer
por: Wang, Yunfeng, et al.
Publicado: (2021)

Detection of the c‐myc Gene Product in Urinary Bladder Cancer
por: Kotake, Toshihiko, et al.
Publicado: (1990)

Myc suppression of Nfkb2 accelerates lymphomagenesis
por: Keller, Ulrich, et al.
Publicado: (2010)

Berberine Inhibits Growth of Liver Cancer Cells by Suppressing Glutamine Uptake
por: Zhang, Pengcheng, et al.
Publicado: (2019)

SLC1A5 glutamine transporter is a target of MYC and mediates reduced mTORC1 signaling and increased fatty acid oxidation in long‐lived Myc hypomorphic mice
por: Zhao, Xiaoai, et al.
Publicado: (2019)

N-Myc downstream-regulated gene 2 suppresses the proliferation of T24 human bladder cancer cells via induction of oncosis
por: HUANG, JIE, et al.
Publicado: (2015)

Glutamine Metabolism in Macrophages: A Novel Target for Obesity/Type 2 Diabetes
por: Ren, Wenkai, et al.
Publicado: (2019)

Glutamine supplementation improves intestinal cell proliferation and stem cell differentiation in weanling mice
por: Chen, Siyuan, et al.
Publicado: (2018)

Oligodendroglioma Cells Lack Glutamine Synthetase and Are Auxotrophic for Glutamine, but Do not Depend on Glutamine Anaplerosis for Growth
por: Chiu, Martina, et al.
Publicado: (2018)

ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis
por: Wu, Baitong, et al.
Publicado: (2022)

Increased Glutamine Consumption in Cisplatin-Resistant Cells Has a Negative Impact on Cell Growth
por: Duan, Guihua, et al.
Publicado: (2018)

FSMP-18. COMPREHENSIVE METABOLIC PROFILING OF HIGH MYC MEDULLOBLASTOMA REVEALS KEY DIFFERENCES BETWEEN IN VITRO AND IN VIVO GLUCOSE AND GLUTAMINE USAGE
por: Pham, Khoa, et al.
Publicado: (2021)

OTME-9. Comprehensive Metabolic Profiling Of high MYC Medulloblastoma Reveals Key Differences Between In Vitro And In Vivo Glucose And Glutamine Usage
por: Pham, Khoa, et al.
Publicado: (2021)

Tripartite motif containing 33 demonstrated anticancer effect by degrading c-Myc: Limitation of glutamine metabolism and proliferation in endometrial carcinoma cells
por: Qi, Yue, et al.
Publicado: (2023)

ELL targets c-Myc for proteasomal degradation and suppresses tumour growth
por: Chen, Yu, et al.
Publicado: (2016)

Glutamine as an Immunonutrient
por: Kim, Hyeyoung
Publicado: (2011)

Glutamine supplementation
por: Wernerman, Jan
Publicado: (2011)

Suppression of Consumption
Publicado: (1899)

Suppression of Consumption
por: Bankston, R. C.
Publicado: (1902)

Cannot write session to /tmp/vufind_sessions/sess_kb52qieb9sudtn4ahvbh8cntqk